PotomacRiver
  • Company
    • Our Story
    • Our Team
    • Our Location
  • Services
    • Policies & Procedures
    • Learning
    • Communications & Engagement
    • Auditing & Monitoring
    • Transparency & Aggregate Spend
    • Operational Excellence
  • Careers
    • What We Do
    • Why Potomac?
    • Current Openings
    • Interview Process
    • Frequently Asked Questions
  • Potomac Thinking
    • Year-in-Review
    • Currents
    • Presentations
    • Brochures
    • Conferences
    • Industry Resources
  • Contact

Potomac Thinking

Industry Resources

Laws and Regulations

  • Enforcement of the Drug Sample Distribution Requirements of the Prescription Drug Marketing Act (PDMA)
  • Federal Anti-Kickback Statute (AKS)
  • Federal Acquisition Regulation (FAR)
  • False Claims Act (FCA)
  • Federal Food, Drug and Cosmetic Act (FDCA)
  • FDA Amendments Act (FDAAA)
  • Foreign Corrupt Practices Act (FCPA)
  • Health Insurance Portability and Accountability Act (HIPAA)
  • Health Information Technology for Economic and Clinical Health Act (HITECH)
  • Patient Protection and Affordable Care Act (PPACA)
  • Prescription Drug Marketing Act (PDMA)
  • Sunshine Act
  • Sunshine Act Final Rule
  • UK Bribery Act

Codes

  • PhRMA Code on Interactions with Healthcare Professionals
  • Statement on Application of Section 2 of PhRMA Code during Emergency Periods
  • PhRMA Conduct of Clinical Trials
  • PhRMA Guiding Principles for DTC Advertisements
  • PhRMA Principles on Interactions with Patient Organizations
  • AdvaMed Code of Ethics
  • MDMA Code of Conduct on Interactions with Healthcare Professionals
  • EFPIA Code of Practice
  • Standards for Integrity and Independence in Accredited Continuing Education

Guidance

  • OIG General Compliance Program Guidance (November 2023)
  • OIG Special Fraud Alert: Speaker Programs (November 2020)
  • DOJ Guidance on Compliance (June 2020)
  • Internet/Social Media Platforms: Correcting Independent Third-Party Misinformation About Prescription Drugs and Medical Devices
  • OIG Compliance Program Guidance (January 2017)
  • OIG Advisory on Patient Travel & Lodging
  • DOJ/SEC FCPA Resource Guide
  • OIG PDMA Guidance
  • FDA PDMA COVID-19 Guidance
  • IFPMA Note for Guidance on Patient and Patient Organization Interactions

Year in Review





    Presentation Download





      PotomacRiver

      1911 N. Fort Myer Dr. Suite 701
      Arlington, VA 22209
      703.430.5944

      • Company
        • Our Story
        • Our Team
        • Our Location
      • Services
        • Policies & Procedures
        • Learning
        • Communications & Engagement
        • Auditing & Monitoring
        • Transparency & Aggregate Spend
        • Operational Excellence
      • Careers
        • What We Do
        • Why Potomac?
        • Current Openings
        • Interview Process
        • Frequently Asked Questions
      • Potomac Thinking
        • Year-in-Review
        • Currents
        • Presentations
        • Brochures
        • Conferences
        • Industry Resources
      • Contact
      © 2025 All Rights Reserved, Potomac River Partners

      Website by LightMix